drugset / Trial / NCT00283621
Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide
Non-randomizedSingle-groupOpen-labelPrevention
Summary
To determine the percentage of patients and number of cycles in which a packed red blood cell transfusion was administered due to anemia and in which antibiotics were administered due to neutropenic fever.
Timeline
- Start
- 2003-06-02
- Primary completion
- 2006-04-12
- Completion
- 2006-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darbepoetin alfa | Protein / enzyme biologic | — | — |
| Subject | Pegfilgrastim | Protein / enzyme biologic | — | — |
| Background | Doxorubicin | Other / unclassified | — | — |
| Background | Ifosfamide | Small molecule | — | — |